Overview –
According to current reports, the Mastitis Market size is expected to develop at a CAGR of 16.20% between 2021 and 2030, reaching USD 53,148.44 million.
The Mastitis market, a significant concern in the dairy industry, reflects a dynamic landscape marked by both challenges and opportunities. Mastitis, inflammation of the mammary gland, poses a threat to milk production and quality. The market is driven by the rising prevalence of mastitis in dairy cows globally, impacting farm productivity and profitability. Key players in the market are focusing on innovative diagnostic tools and therapeutics to address this issue. Additionally, growing awareness about the economic implications of mastitis and the importance of preventive measures is shaping market dynamics. As the industry strives for sustainable and efficient dairy production, the Mastitis market remains a pivotal segment in agribusiness.
The mastitis market focuses on diagnosing and treating the inflammation of breast tissue, typically caused by bacterial infection during breastfeeding. Mastitis symptoms include breast pain, swelling, warmth, and redness. The market offers various therapies, including antibiotics and pain relievers, to alleviate symptoms and prevent complications. Growing awareness and innovative treatment options drive market growth.
Segmentation-
The segmentation of the global mastitis market is based on type, treatment, end-user, and region. In terms of type, the market distinguishes between human mastitis and bovine mastitis, with the latter dominating the market in 2017. Among bovine mastitis, contagious mastitis held a significant share, valued at USD 3,843.23 million in 2017, with a projected CAGR of 16.91% from 2017 to 2023. Environmental mastitis comprised 38% of the bovine mastitis segment in 2017.
Regarding treatment, the mastitis market encompasses antibiotics, pain relievers, surgery, vaccines, and others. Antibiotics for bovine treatment amounted to USD 6,448.56 million in 2017, and the subsegment is anticipated to exhibit a CAGR of 16.56% during the forecast period.
In terms of end-users, the mastitis market is segmented into hospitals, clinics, veterinary centers, and others. In 2018, hospitals and clinics are expected to hold the largest share. Veterinary centers dominated the market in 2017, accounting for approximately USD 6,326.34 million, and are projected to register a CAGR of 16.87% over the forecast period.
Regional Analysis -
The global mastitis market undergoes regional analysis, with the Americas taking the lead, propelled by higher healthcare expenditures and a rising prevalence of mastitis in the bovine population. The US, supported by a surge in human and bovine mastitis cases, serves as a primary growth contributor, with the North American mastitis market projected to reach USD 7,054.58 million by 2023.
Following closely, Europe secures the second position globally in the mastitis market, attributed to a high prevalence of breast cancer. Access to advanced treatment facilities, government initiatives promoting healthy breastfeeding, and increasing healthcare expenditures contribute to the region's growth. The European mastitis market is anticipated to be valued at USD 5,275.18 million by 2023.
The Asia Pacific region emerges as a promising market in the mastitis landscape, experiencing rapid growth driven by government healthcare reforms. The demand for advanced treatment therapies, particularly in China and India, propels market expansion. The mastitis market in the Asia Pacific is poised to reach a valuation of USD 5,000.41 million by 2023.
Key Players –
Key players in the mastitis market include Bayer AG (Germany), Pfizer Inc. (U.S.), BioNumerik Pharmaceuticals Inc. (U.S.), Zoetis Inc. (U.S.), Sanofi S.A. (France), Merck Co & Inc. (U.S.), Oncothyreon Inc. (U.S.), Oncogenex (U.S.), Apthera Inc. (U.K.), Astellas Pharma Inc. (Japan), Novartis AG (Switzerland), Boehringer Ingelheim GmbH (Germany), and F. Hoffmann-La Roche Ltd. (Switzerland).
These prominent entities in the market strategically engage in initiatives such as mergers, acquisitions, product launches, and other maneuvers. These strategic moves not only contribute to the individual growth of these companies but also play a pivotal role in driving the overall expansion of the mastitis market.
For more information visit at MarketResearchFuture
